Sanofi
Global
About Us
About Us
At a glance
Our journey through time
Making in India
Sanofi India Leadership Team
Chasing Miracles of Science
Chasing Miracles of Science
Protecting with vaccines
Solutions in Diabetes
Fighting rare diseases
Dare to Know Epilepsy
Transforming lives with transplantation
Our Science
Our Science
Clinical Trials & Results
Clinical Trials & Results
Multiple Sclerosis
Pharmaceutical products
Vaccines
Specialty Care Products
For healthcare professionals
Social Impact
Social Impact
Access to health
Engaged communities
Environmental impact
Ethics & transparency
Consumer Healthcare
Consumer Healthcare
Health & well-being
Consumer Healthcare Products
Consumer Healthcare Products
All Products
Dulcoflex® - Constipation Relief Brand
For healthcare professionals
Investors
Investors
Our Business
Board of Directors and Leadership Team
Financial Results
Annual Reports
AGM
Investor Information
Disclosures Under Reg-46 of the Listing Regulations
CSR
Shareholder Corner
Scheme of Arrangement
Media
Media
Media Release
Media
Media
Press Releases
Company statements
Investors
Investors
Board of Directors and Leadership Team
Board of Directors and Leadership Team
Board of Directors
Directorships and full-time positions
Board Committees
Sanofi India Limited Leadership Team
Financial Results
Annual Reports
AGM
Scheme of Arrangement
Investor Information
Investor Information
Shareholding pattern
Corporate Governance
Analyst / Investor Meet
Postal Ballot
Secretarial Compliance Report
Related Party Disclosures
Annual Return
Stock Exchange Announcement and Disclosures
Newspaper Advertisement
Disclosures Under Reg. 46 of the Listing Regulations
Disclosures Under Reg. 46 of the Listing Regulations
Our Business
Letter of Appointment of Independent Directors
Composition of Board Committee
Code of Conduct and Policies
Familiarization Programme
Contact information for grievance redressal
Notice of Board Meeting
Financial results
Annual Reports
Shareholding Pattern
Analyst Meet
Notice given to shareholders by way advertisement
Audited Financial Results of Subsidiary
Secretarial Compliance Report
Policy for Determination of Materiality
KMP authorized for Determination of Materiality
Disclosures under Reg. 30 of the Listing Regulations
Memorandum and Articles of Association
Annual Return
CSR
Shareholder’s Corner
Shareholder’s Corner
Unclaimed Dividends
Unpaid Dividends
Unclaimed shares
Investor services
Contact Us
Careers
Careers
Working at Sanofi
Hyderabad Hub
Contact Us
India
Stock Exchange Announcement and Disclosures
Stock Exchange Announcement and Disclosures
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2025
Announcement under Regulation 30 of SEBI LODR – Resignation of Chief Financial Officer and Senior Management Personnel (PDF)
Submission of Recommendations by the Committee of Independent Directors pursuant to Regulation 26(7) of SEBI (SAST) Regulations, 2011 (PDF)
Change in Record Date of Dividend (PDF)
Intimation of Book Closure pursuant to Regulation 42 of the SEBI (LODR) Regulations, 2015
Outcome of 20th February 2025 Board Meeting
Change in Name of Registrar and Share Transfer Agent
Intimation for Board Meeting 20th February 2025
Intimation for Shifting of Registered Office of the Company
STOCK EXCHANGE ANNOUNCEMENT AND DISCLOSURES 2024
Announcement Under Regulation 30 Lodr Resignation of Chief Financial Officer CFO
Announcement Under Regulation 30 of Sebi Lodr
Announcement Under Regulation 30 of Sebi Lodr 1
Appointment of CFO
Disclosure Under Regulation 30a of Lodr
Disclosure Under Regulation 30a of Lodr 2
Disclosure Under Sebi PIT Regulations 2015
Disclosure Under Sebi PIT Regulations 2015 2
Disclosure Under Sebi PIT Regulations 2015 3
Intimation for Board Meeting 12th November 2024
Outcome for 12 Nov 2024 Board Meeting
Trading Window Closure Dec 2024
Trading Window Closure Sept 2024
